OGEN trade ideas

DEXWireNews

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oragenics Inc (OGEN) today and set a price target of $2. The company’s shares closed yesterday at $0.55, close to its 52-week low of $0.38. Selvaraju observed: “We believe the Phase 2 study could report top-line results in early 2020. If AG013 could significantly reduce the duration and lower the...

TeeMiner Updated 

Looking very bullish@ 15,30,45 and 1h time frame. Order is set @ .99 target 5-20 % stop loss .95 Oragenics Fast Track Drug AG013 Going into Phase II Clinicals

TradeWithTyler

If we can break through support and test it, then we will have confirmation to the next level.

RocketTickers

OGEN: oragenics inc 2018-05-30 07:30:03 Detected possible positive results in drug trial

steaksndwch

DOWN TOWN

tdfish

TP 1 @ 1.2 TP 2 @ 1.1 Stop @ 2.11

n.c_trader

I think Ogen will move up in nexts weeks/months to 2,50$ zone. His chart it's very nice a shows a nice ascending triangle